13F-HR filed by Commodore Capital LP
Commodore Capital LP filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-15, with 32 holding rows worth $656,834,859.
- Accession
- 0001831942-23-000007
- Filer
- CIK 1831942
- Filed
- 2023-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2023
A holdings report, 32 entries on the cover page, a total value of $656,834,859 stated on the cover page (in dollars after the unit check, H1), rows summing to $656,834,859 with VALUE read as dollars as filed, 13F file number 028-20976. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 1,845,000 | $66,032,550 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 2,189,659 | $55,704,925 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 2,950,000 | $54,280,000 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 4,772,421 | $51,494,423 | dollars as filed | |
| BELLUS HEALTH INC NEW | 07987C204 | COM | 6,579,359 | $47,371,385 | dollars as filed | |
| AMBRX BIOPHARMA, INC. SPONSORED ADR | 02290A102 | COM | 4,803,447 | $42,846,747 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 1,731,365 | $37,916,894 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 790,000 | $30,225,400 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 1,075,000 | $28,046,750 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 1,440,999 | $22,349,894 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 2,824,029 | $21,914,465 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 853,884 | $18,034,030 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 495,823 | $17,839,712 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 2,025,000 | $17,658,000 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 1,835,000 | $15,175,450 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 1,204,958 | $14,736,636 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 575,000 | $14,605,000 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 1,390,772 | $14,255,413 | dollars as filed | |
| PROMETHEUS BIOSCIENCES INC | 74349U108 | COM | 127,156 | $13,646,382 | dollars as filed | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 1,325,000 | $10,229,000 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 739,661 | $9,889,268 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 590,705 | $9,067,322 | dollars as filed | |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 217,253 | $8,785,711 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 1,900,000 | $8,455,000 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 200,000 | $7,496,000 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 635,000 | $5,137,150 | dollars as filed | |
| THIRD HARMONIC BIO INC | 88427A107 | COM | 993,294 | $4,092,371 | dollars as filed | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 5,000,000 | $3,587,000 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 312,553 | $2,456,667 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 898,267 | $1,724,673 | dollars as filed | |
| ACUMEN PHARMACEUTICALS INC | 00509G209 | CMN | 400,000 | $1,624,000 | dollars as filed | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 92,687 | $156,641 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001831942-23-000007 | this filing | 2023-05-15 | acceptance time not in the bulk data set |